NDC11 00409508611
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00409-5086-11 | 00409-5086 |
| 0409-5086-11 | 0409-5086 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 1ab5ae3e-e303-4499-4c89-472d7cc1e46c | 2024-07-04 | Warnings, Adverse reactions | 0409-5086-11 0409-5086 00409508611 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.